Syros Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
21 Dec 23 | BuyUS$3,999,998 | Samsara BioCapital LLC | Company | 904,977 | US$4.42 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 95 | 0.000355% |
Individual Insiders | 438,218 | 1.64% |
General Public | 3,974,592 | 14.9% |
Hedge Funds | 5,217,223 | 19.5% |
VC/PE Firms | 8,534,500 | 31.9% |
Institutions | 8,563,709 | 32% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 29.8%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
2,749,808 | US$15.9m | 0% | 1.62% | |||
2,505,013 | US$14.5m | 0% | 0.34% | |||
2,071,914 | US$12.0m | 0% | 0.02% | |||
1,786,427 | US$10.4m | 0% | 2.31% | |||
1,673,538 | US$9.7m | 0% | 0.38% | |||
1,493,252 | US$8.7m | 338% | 3.09% | |||
1,471,771 | US$8.5m | 0% | 0.02% | |||
1,293,849 | US$7.5m | 0% | 0.76% | |||
928,046 | US$5.4m | 21.3% | no data | |||
787,545 | US$4.6m | 119% | 1.08% | |||
531,914 | US$3.1m | 0% | 0.09% | |||
528,190 | US$3.1m | 0% | 0.17% | |||
446,591 | US$2.6m | 86.3% | no data | |||
404,914 | US$2.3m | 0% | 0.05% | |||
284,936 | US$1.7m | 0% | 0.01% | |||
261,083 | US$1.5m | 0% | no data | |||
257,041 | US$1.5m | 4.09% | no data | |||
251,270 | US$1.5m | 0% | 0.94% | |||
233,000 | US$1.4m | 192% | 0.45% | |||
220,245 | US$1.3m | 36.3% | no data | |||
175,000 | US$1.0m | 34.6% | 0.09% | |||
172,517 | US$1.0m | 716% | no data | |||
169,999 | US$986.0k | 576% | no data | |||
159,584 | US$925.6k | 543% | no data | |||
154,989 | US$898.9k | 49.7% | 0.01% |